The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence article

Cell Death and Disease

Volumn 9, Issue 3, 2018, Pages

  Ong, Siew Min ^a   Hadadi, Eva ^a   Dang, Truong Minh ^a   Yeap, Wei Hseun ^a   Tan, Crystal Tze Ying ^a   Ng, Tze Pin ^b   Larbi, Anis ^a   Wong, Siew Cheng ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MATRIX METALLOPROTEINASE; MICRORNA 146A; MITOGEN ACTIVATED PROTEIN KINASE; RANTES; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; AUTACOID; CD14 PROTEIN, HUMAN; CYTOKINE; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IL1A PROTEIN, HUMAN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE RECEPTOR; LIPOPOLYSACCHARIDE, ESCHERICHIA COLI O111 B4; MICRORNA; MIRN146 MICRORNA, HUMAN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CELL AGING; CELL PROLIFERATION; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MONOCYTE; OSTEOARTHRITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; STIMULUS RESPONSE; TELOMERE LENGTH; AGE; AGING; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MITOCHONDRION; PATHOLOGY; SIGNAL TRANSDUCTION; TELOMERE HOMEOSTASIS; YOUNG ADULT;

ADULT; AGE FACTORS; AGING; CELL PROLIFERATION; CELLS, CULTURED; CELLULAR SENESCENCE; CYTOKINES; FEMALE; GPI-LINKED PROTEINS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1ALPHA; LIPOPOLYSACCHARIDE RECEPTORS; LIPOPOLYSACCHARIDES; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICRORNAS; MIDDLE AGED; MITOCHONDRIA; MONOCYTES; NF-KAPPA B; PHENOTYPE; REACTIVE OXYGEN SPECIES; RECEPTORS, IGG; SIGNAL TRANSDUCTION; TELOMERE HOMEOSTASIS; YOUNG ADULT;

EID: 85042194401     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/s41419-018-0327-1     Document Type: Article

References (58)

1. Passlick, B., Flieger, D. & Ziegler-Heitbrock, H. W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527-2534 (1989).
2. Stansfield, B. K. & Ingram, D. A. Clinical significance of monocyte heterogeneity. Clin. Transl. Med 4, 5 (2015).
3. Belge, K. U. et al. The proinflammatory CD14+CD16+DR++monocytes are a major source of TNF. J. Immunol. 168, 3536-3542 (2002).
4. Frankenberger, M., Sternsdorf, T., Pechumer, H., Pforte, A. & Ziegler-Heitbrock, H. W. Differential cytokine expression in human blood monocyte subpopulations: A polymerase chain reaction analysis. Blood 87, 373-377 (1996).
5. Mukherjee, R. et al Non-Classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous. Sci. Rep. 5, 13886 (2015).
6. Wong, K. L. et al. The three human monocyte subsets: implications for health and disease. Immunol. Res 53, 41-57 (2012).
7. Yang, J., Zhang, L., Yu, C., Yang, X. F. & Wang, H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark. Res 2, 1 (2014).
8. Dang, T. M. et al. MicroRNA expression profiling of human blood monocyte subsets highlights functional differences. Immunology 145, 404-416 (2015).
9. Taganov, K. D., Boldin, M. P., Chang, K. J. & Baltimore, D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481-12486 (2006).
10. Bhaumik, D. et al MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging 1, 402-411 (2009).
11. Li, G., Luna, C., Qiu, J., Epstein, D. L. & Gonzalez, P. Modulation of inflammatory markers by miR-146a during replicative senescence in trabecular meshwork cells. Invest Ophthalmol. Vis. Sci. 51, 2976-2985 (2010).
12. Olivieri, F. et al MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age 35, 1157-1172 (2013).
13. Salama, R., Sadaie, M., Hoare, M. & Narita, M. Cellular senescence and its effector programs. Genes Dev. 28, 99-114 (2014).
14. Herbig, U., Ferreira, M., Condel, L., Carey, D. & Sedivy, J. M. Cellular senescence in aging primates. Science 311, 1257 (2006).
15. Tominaga, K. The emerging role of senescent cells in tissue homeostasis and pathophysiology. Pathobiol. Aging Age Relat. Dis. 5, 27743 (2015).
16. Coppe, J. P., Desprez, P. Y., Krtolica, A. & Campisi, J. The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu Rev. Pathol. 5, 99-118 (2010).
17. Rajagopalan, S. & Long, E. O. Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc. Natl. Acad. Sci. USA 109, 20596-20601 (2012).
18. Pita-Lopez, M. L. et al. Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors. Immun. Ageing 6, 11 (2009).
19. Cudejko, C. et al. p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages. Blood 118, 2556-2566 (2011).
20. van Furth, R. & Cohn, Z. A. The origin and kinetics of mononuclear phagocytes. J. Exp. Med 128, 415-435 (1968).
21. Wong, K. L. et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118, e16-e31 (2011).
22. Zhao, C. et al. The CD14(+/low)CD16(+) monocyte subset is more susceptible to spontaneous and oxidant-induced apoptosis than the CD14(+)CD16(-) subset. Cell Death Dis. 1, e95 (2010).
23. Clanchy, F. I., Holloway, A. C., Lari, R., Cameron, P. U. & Hamilton, J. A. Detection and properties of the human proliferative monocyte subpopulation. J. Leukoc. Biol. 79, 757-766 (2006).
24. Patel, A. A. et al. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J. Exp. Med 214, 1913-1923 (2017).
25. Ziegler-Heitbrock, L. et al. Nomenclature of monocytes and dendritic cells in blood. Blood 116, e74-e80 (2010).
26. Cho, S. & Hwang, E. S. Fluorescence-based detection and quantification of features of cellular senescence. Methods Cell Biol. 103, 149-188 (2011).
27. Cagnol, S. & Chambard, J. C. ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J. 277, 2-21 (2010).
28. Salminen, A., Kauppinen, A. & Kaarniranta, K. Emerging role of NF-kappaB signaling in the induction of senescence-associated secretory phenotype (SASP). Cell Signal 24, 835-845 (2012).
29. Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K. & Campisi, J. Cell surface-bound IL-1alpha is an upstream regulator of the senescenceassociated IL-6/IL-8 cytokine network. Proc. Natl. Acad. Sci. USA 106, 17031-17036 (2009).
30. Fulop, T., Dupuis, G., Witkowski, J. M. & Larbi, A. The role of immunosenescence in the development of age-related diseases. Rev. Invest Clin. 68, 84-91 (2016).
31. Nahid, M. A., Pauley, K. M., Satoh, M. & Chan, E. K. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J. Biol. Chem. 284, 34590-34599 (2009).
32. Vicente, R., Mausset-Bonnefont, A. L., Jorgensen, C., Louis-Plence, P. & Brondello, J. M. Cellular senescence impact on immune cell fate and function. Aging Cell 15, 400-406 (2016).
33. Seshadri, T. & Campisi, J. Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science 247, 205-209 (1990).
34. Ye, X. et al. Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells. Mol. Cell 27, 183-196 (2007).
35. van Deursen, J. M. The role of senescent cells in ageing. Nature 509, 439-446 (2014).
36. Ancuta, P. et al. Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+and CD16-monocyte subsets. BMC Genom. 10, 403 (2009).
37. Ziegler-Heitbrock, H. W. et al. The novel subset of CD14+/CD16+blood monocytes exhibits features of tissue macrophages. Eur. J. Immunol. 23, 2053-2058 (1993).
38. Zhao, C. et al. Identification of novel functional differences in monocyte subsets using proteomic and transcriptomic methods. J. Proteome Res 8, 4028-4038 (2009).
39. Kreiling, J. A. et al. Age-associated increase in heterochromatic marks in murine and primate tissues. Aging Cell 10, 292-304 (2011).
40. Jeyapalan, J. C. & Sedivy, J. M. Cellular senescence and organismal aging. Mech. Ageing Dev. 129, 467-474 (2008).
41. Hearps, A. C. et al. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell 11, 867-875 (2012).
42. Lu, Y. et al. Inflammatory and immune markers associated with physical frailty syndrome: findings from Singapore longitudinal aging studies. Oncotarget 7, 28783-28795 (2016).
43. Sadeghi, H. M., Schnelle, J. F., Thoma, J. K., Nishanian, P. & Fahey, J. L. Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp. Gerontol. 34, 959-970 (1999).
44. Verschoor, C. P. et al. Alterations to the frequency and function of peripheral blood monocytes and associations with chronic disease in the advanced-age, frail elderly. PLoS One 9, e104522 (2014).
45. Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J. & Kirkland, J. L. Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities. J. Clin. Invest 123, 966-972 (2013).
46. Freund, A., Orjalo, A. V., Desprez, P. Y. & Campisi, J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med 16, 238-246 (2010).
47. Lescoat, A. et al. CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis. Clin. Rheumatol. 36, 1649-1654 (2017).
48. Zhang, J. Y. et al Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS ONE 6, e17484 (2011).
49. Wallquist, C., Paulson, J. M., Hylander, B., Lundahl, J. & Jacobson, S. H. Increased accumulation of CD16+monocytes at local sites of inflammation in patients with chronic kidney disease. Scand. J. Immunol. 78, 538-544 (2013).
50. Rogacev, K. S. et al. Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur. Heart J. 31, 369-376 (2010).
51. Chiu, Y. G. et al. CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Res Ther. 12, R14 (2010).
52. Idzkowska, E. et al The role of different monocyte subsets in the pathogenesis of atherosclerosis and acute coronary syndromes. Scand. J. Immunol. 82, 163-173 (2015).
53. Kapinsky, M. et al. Enzymatically degraded LDL preferentially binds to CD14 (high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36. Arterioscler. Thromb. Vasc. Biol. 21, 1004-1010 (2001).
54. Childs, B. G. et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 354, 472-477 (2016).
55. Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageingassociated disorders. Nature 479, 232-236 (2011).
56. Fingerle-Rowson, G., Angstwurm, M., Andreesen, R. & Ziegler-Heitbrock, H. W. Selective depletion of CD14+CD16+monocytes by glucocorticoid therapy. Clin. Exp. Immunol. 112, 501-506 (1998).
57. Korkosz, M., Bukowska-Strakova, K., Sadis, S., Grodzicki, T. & Siedlar, M. Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14(++)CD16(+)/CD14 (+)CD16(++)) monocytes in rheumatoid arthritis patient. Blood 119, 5329-5330 (2012).
58. Siedlar, M. et al. Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++monocytes in common variable immunodeficiency (CVID) patients. Clin. Immunol. 139, 122-132 (2011).